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INTRODUCTION
Anxiety is a complex physiological and behavioral alteration 
of the organism, which ultimately leads to wide variety of central 
nervous system (CNS) disorders, if untreated. In addition to indi‑
vidual genetic factors, external influences such as nutrition, smok‑
ing, alcohol, socioeconomic status, environmental conditions, etc., 
can strongly contribute to its anticipated appearance.[1] Globally, 
anxiety affects one‑eighth of the population and has become an im‑
portant research area for brain disorders and psychopharmacology.[2] 
Excessive anxiety can debilitate and damage the quality of healthy 
and wealthy life. Anxiolytic drugs are one of the most frequently 
prescribed drugs as the disease is highly prevalent in the society.[3]
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ABSTRACT
The present study was undertaken to evaluate anxiolytic effect of 70% hydroethanolic extract of leaves of Cissampelos pareira in murine 
models. C. pareira (Menispermaceae) is rich in alkaloids, and phytochemical results showed that it contains alkaloids, flavanoids, 
terpenoids, steroids, etc., Anxiolytic activity was evaluated by using elevated plus maze test (EPM), light dark (LandD) model, and 
forced swim test (FS) models in rats. The efficacy of extract (100, 200, 400 mg/kg) was compared with control as well as standard 
diazepam (DZ; 2 mg/kg, p.o.) in EPM, LandD model, and imipramine (IM; 2.5 mg/kg, p.o.) in FS model. The results showed that 
DZ and extract significantly increased the number of entries, time spent in open arm, head dip counts, and rearing time, while they 
decreased fecal count in EPM. DZ and extract also significantly increased the number of crossings and time spent in light compartment, 
while they decreased duration of immobility in LandD model. In case of FS model, IM and extract significantly increased mobility and 
swimming time. Thus, the results confirm that hydroethanolic extract of C. pareira has the potential to be used in the management of 
anxiety‑like behavior in a dose of 200 and 400 mg/kg. Further study is required to explore the plant and its parts for anxiolytic potential.
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Benzodiazepines (BZDs), gamma‑aminobutyric acid 
(GABA) A receptor agonist, and buspirone, a 5‑hydroxytrypta‑
mine (5‑HT) 1A receptor agonist, are mainly used in the clinical 
treatment of anxiety and their regular use results in physical and 
pharmacological dependence. They have other serious concerns and 
problems such as rebound insomnia, sedation, muscle relaxation, 
withdrawal, tolerance (BZDs, barbiturates, and alcohol), and sexual 
dysfunction. Anticholinergic and antihistaminic effects (tricyclic 
antidepressants, TCAs) have limited their use in patients.[3,4] Psy‑
chopharmacological research in the treatment of anxiety and stress 
is very much influenced by the availability of anxiolytic drugs.[5] 
Drawbacks of the medicines have forced many pharmaceutical com‑
panies to conduct research for alternative medicines or plant‑derived 
medicines to reduce the CNS disorders like anxiolytic effects.[6]
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India has a rich repository of biodiversity and knowledge 
in the use of “folk” herbal medicines to cure many ailments in 
various cultures and tribes.[5] Cissampelos pareira, belonging to 
family Menispermaceae, is one of the important plants in Indian 
history, which is traditionally used in the treatment of anxiety, 
psychological and brain disorders. Historically, it has been used 
as an anti‑inflammatory, smooth muscle relaxant, antispasmodic, 
as a uterine muscle relaxant, for menstrual disorders (includ‑
ing cramping and pain), and is reported to have antiulcerous, 
anti‑hemorrhagic, anti‑fertility, anti‑nociceptive, antimalarial, 
antibacterial activities, etc.[7‑9] C. pareira has also been reported to 
possess immunomodulatory activity.[10] The roots and leaves contain 
several alkaloids and volatile oil. C. pareira is reported to contain 
stetradrine, berberine, cissampeline, bulbocapnine, cissamine, 
cissampareine, corytuberine, curine, 4‑methylcurine, cyclanoline, 
cycleanine, dicentrine, dehydrodicentrine, dimethyltetrandrinium, 
grandirubrine, hayatine, hayatinine, insularine, isochondodendrine, 
isomerubrine, laudanosine, linoleic acid, magnoflorine, menismine, 
norimeluteine, nor‑ruffscine, nuciferine, pareirine, pareirubrine, 
pareitropone, quercitol, and stearic acid.[8] Literature survey of 
C. pareira has revealed that its CNS activity or on traditional use 
validation has not been studied much, so the present study was con‑
ducted to determine the anxiolytic effect of hydroethanolic extract 
of leaves of C. pareira by using different animal models of anxiety.
MATERIALS AND METHODS
Plant material
The plant material was collected from Bilaspur district in 
Himachal Pradesh, India. Plant material was identified and authen‑
ticated by Prof. Zulfiquar Ali Bhat, Department of Pharmaceutical 
Sciences, University of Kashmir, Srinagar, India (voucher speci‑
men number AUKU/012).
Drying and size reduction
Plant leaves were subjected to shade drying for about 1 week. 
The dried plant material was further crushed to powder and the 
powder was passed through sieve mesh no. 40 and stored in an 
air‑tight container for further analysis.
Extraction of plant material
The coarsely powdered material (100 g) was extracted using 
70% ethanol as a solvent with simple maceration process at room 
temperature. Extract was concentrated and dried at 40‑50°C using 
vacuum distillation assembly. The hydroethanolic extract of C. pa-
reira (HEECP) yielded a thick brown semisolid residue (20%). The 
extract was subjected to preliminary phytochemical screening.[11,12]
Animals
Adult albino rats (130–160 g) of either sex were obtained from 
the animal house of Sanjay Biological in Amritsar, Punjab, India. 
The animals were maintained in a well‑ventilated room with 12:12 h 
light/dark cycle in polypropylene cages with standard pellet chow 
and water ad libitum. Animals were divided into five groups with five 
rats in each group. Institutional Animal Ethical Committee approved 
the protocol of the study (approval no. RIP/IAEC/2012‑13/11). The 
experiments were conducted as per the approved protocol. Animals 
were acclimatized to laboratory conditions 1 week prior to initiation 
of experiments. This institution is approved by (CPCSEA) Com‑
mittee for the Purpose of Control and Supervision of Experiments 
on Animal Government of India, for carrying out animal studies.
Drugs and chemicals
Diazepam (DZ) was purchased from Ranbaxy Laboratories 
Limited, Himachal Pradesh State Industrial Development Corpo‑
ration (HPSIDC), Baddi, Solan, India and imipramine (IM) from 
Pfizer Ltd., Mumbai, India. Ethanol and sodium carboxymethyl 
cellulose were purchased from Spruce Enterprises Ambala Cant, 
Haryana, India. DZ, IM, and test drugs (100, 200, and 400 mg/kg) 
were suspended in a 1% sodium carboxymethyl cellulose solu‑
tion. All the dosages were prepared immediately before use and 
administered orally. Control rats received 1% aqueous sodium car‑
boxymethyl cellulose solution only. The effects of the drugs were 
estimated 60 min after drug administration. Tests were performed 
only after the rats had been acclimatized to the experimental en‑
vironment for 7 days. All experiments were carried out between 
09:00 and 16:00 h. In each experiment, the apparatus was cleaned 
using 5% ethanol.
Acute toxicity study
Acute toxicity study was conducted as per the internationally 
accepted protocol drawn under the OECD (Organisation for Eco‑
nomic Co‑operation and Development) guidelines 425 (OECD, 
2001). Overnight fasted, healthy rats (n = 3) were administered 
orally the extract of hydroethanolic plant material in doses of 1600 
and 3200 mg/kg body weight and observed continuously for 4 h 
and after 24 h for any abnormality and mortality. Hydroethanolic 
extract at a dose level of 3200 mg/kg was found to be safe. Doses 
of 100, 200, and 400 mg/kg were selected as the experimental 
dose of extracts for anti‑anxiety studies.
Elevated plus maze model
Elevated plus maze 
In brief, the apparatus was composed of two open 
arms (50 × 10 cm) and two enclosed arms of the same size with 
40‑cm‑high wall arranged in such a way that the arms of the same 
type were opposite to each other with a central square of 10 cm to 
form a plus sign. The apparatus was wooden and was elevated to a 
height of 50 cm above the floor level by a single central support. 
A slightly raised edge on the open arms (0.25 cm) provided addi‑
tional grip for the animals, whereas open arm activity was further 
encouraged by testing in a dimly lit room. The experiment was 
conducted between 9:00 and 16:00 h. To facilitate adaptation to 
new surroundings, rats were transported to the laboratory at least 
1 h prior to testing. The trial was started by placing an animal on the 
central platform of the maze facing an open arm. Standard 5‑min 
test duration was used for the animals. The maze was thoroughly 
cleaned. Rats were randomly allocated to the following groups: 
vehicle control; positive control: DZ (2 mg/kg, p.o.); and test drugs. 
The experiments were performed with an observer aware of the 
treatment of the rats inside the room. The following parameters 
were classically measured in this test: frequency and duration (s) of 
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arm visits, separately for open and closed arms. A rat was consid‑
ered to have entered an arm when all four paws were on the arm. 
The number of entries into open arms, closed arms), and the time 
spent in open or closed arms were used as traditional indices of 
the anxiety. In addition, the latency time (time spent at the center 
of the maze), head dip count, rearing count and duration, and fecal 
bolus (stool bal) count were also recorded.[2,13‑15]
Light dark (LandD) model
The apparatus consisted of an open top wooden box. Two 
distinct chambers, a black chamber (20 × 30 × 35 cm) painted 
black and illuminated with dimmed red light and a bright cham‑
ber (30 × 30 × 35 cm) painted white and brightly illuminated 
with 100 W white light source, were located 17 cm above the 
box. The two chambers were connected through a small open 
doorway (7.5 × 5 cm) situated on the floor level at the center of 
the partition. Each animal was in bright and dark arena paradigm. 
Sixty minutes after the drug administration [DZ (2 mg/kg, p.o.), 
test drugs (100, 200, and 400 mg/kg, p.o.)] or vehicle administra‑
tion, the animal was placed at the center of the brightly lit arena in 
the light and dark box. Time spent in the light arena, time spent in 
dark arena, number of crossings, and duration of immobility were 
noted for 10 min for each trial. Following each trial, the apparatus 
was cleaned to mask the odor left by the animal in the previous 
experiment. Hand‑operated counters and stop watches were used 
to score the behavior of animals, and experiments were performed 
with an observer inside the room.[2,4,14,15]
Forced swim test (FST)
Rats’ responses were evaluated in a glass tank (23 cm × 30 cm; 
height, 40 cm; Techno) filled to a depth of 28 cm with water at 
22°C. The rats could not touch the bottom of the glass tank. 
The glass tank was illuminated indirectly and surrounded by 
dark brown shading walls (distance from the tank, 20 cm) to 
screen the view from the experimenter. The experiments were 
done between 9:00 and 16:00 h in accordance with a described 
method.[15] On the first experimental day, rats were placed gently 
in the water for a 15‑min period of habituation. Upon removal 
from the water, they were placed in a standard Plexiglas box 
with the floor covered with paper towels. They were then placed 
under an infrared heater for 30 min to dry. The next day, they 
were placed once more gently into the glass tank and observed 
for 5 min. The behavior of the rats was recorded. At the end of 
the 5‑min period, the rats were transferred to the infrared heated 
box and allowed to dry. During the experiment, the data noted 
or recorded were evaluated manually and the duration of the 
following behaviors was recorded, i.e. immobility (floating and 
making only those movements necessary to keep the nose above 
the water and swimming) and active motions (i.e., moving around 
the tank, including diving). Rats were randomly allocated to the 
following groups: vehicle control, IM (2.5 mg/kg, p.o.), and test 
drug (100, 200, and 400 mg/kg, p.o.). The experiments were done 
with an observer in the room.[5,16]
Statistical analysis
All observations were presented as Mean ± SEM and were 
analyzed using one‑way analysis of variance (ANOVA) followed 
by Dunnett’s “t”‑test (*P < 0.05, **P < 0.01, ***P < 0.001). 
P values lower than 0.05 were considered statistically significant.
RESULTS
Phytochemical screening
Preliminary phytochemical screening of HEECP showed 
that the plant contains alkaloids, terpenoids, carbohydrates, and 
phenolic/tannins, but proteins, saponins, steroids, and glycoside 
were absent [Table 1].
Effect of DZ (2 mg/kg, p.o.) and HEECP on the time spent 
in open/closed arm and latency (time spent in the center of 
maze) in animals of the EPM model
Standard group (DZ, 2 mg/kg) showed significant increase in the 
time spent in open arm (171.67 ± 20.5 sec; ***P < 0.001) as com‑
pared to the control group (10.6 ± 2.92 sec), which indicates reduc‑
tion in the anxiety. Significant increase in the time spent in open arm 
was observed with test doses of HEECP at 100, 200, and 400 mg/
kg, i.e. 73.5 ± 5.61 sec (***P < 0.001), 84 ± 5.4 sec (***P < 0.001), 
and 87.8 ± 3.24 sec (***P < 0.001), respectively, in comparison with 
the control group. In a similar fashion, to determine the potency of 
the extract, test groups were compared with standard group. Test 
group doses (100, 200, and 400 mg/kg) showed significant differ‑
ence (***P < 0.001) compared to the standard drug in reduction of 
anxiety. Potency of the test drug (400 mg/kg) was found to be lesser 
than the standard group (DZ). DZ and test doses showed significant 
decrease in the time spent in closed arm as compared to the control 
group, which indicates anxiolytic effect. Test group doses (100, 
200, and 400 mg/kg) showed significant difference (***P < 0.001) 
compared to the standard drug in reduction of anxiety. DZ and 
HEECP (100, 200, and 400 mg/kg) showed significant decrease 
in latency as compared to the control group. Test groups (100 and 
400 mg/kg) showed insignificant difference compared to the stan‑
dard, but the other test group (200 mg/kg) showed significant differ‑
ence (**P < 0.01) in comparison. Potency of the test group (200 mg/
kg) was found to be greater than the standard group. Results are 
presented in Figure 1. Absence of a and b values in the graph indicate 
insignificant or insignificant group.
Effect of DZ and HEECP on the number of entries in open/
closed arm in animals of the EPM model
Standard group (DZ, 2 mg/kg) showed significant increase 
in the number of entries in open arm (8.50 ± 1.50; P < 0.001) as 
Table 1: Phytochemical screening of hydroethanolic extract of 
Cissampelos pareira
Extract constituents Present (+)/Absent (‑)
Alkaloids +
Terpenoids +
Carbohydrates +
Phenolic/tannins +
Proteins −
Saponins −
Steroids −
Glycosides −
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compared to the control group (0.33 ± 0.01), which indicates re‑
duction in anxiety. Insignificant increase in the number of entries 
in open arm was observed with HEECP 100, 200, and 400 mg/kg, 
i.e. 3 ± 0.33, 3 ± 0.03, and 4 ± 0.23, respectively, in comparison 
with the control group. Test groups (100 and 200 mg/kg) showed 
significant difference (***P < 0.001), while 400 mg/kg showed 
significant difference of **P < 0.01 on comparing with the standard 
group. Potency of the test group (400 mg/kg) was found to be lesser 
than the standard group [Figure 2]. Standard group showed signifi‑
cant decrease in the number of entries in closed arm (1.83 ± 0.40; 
P < 0.01) as compared to the control group (7.17 ± 0.79). There 
was insignificant decrease in the number of entries in closed 
arm with HEECP at doses 100 and 200 mg/kg, i.e. 5 ± 0.89 and 
4.17 ± 0.70, respectively, and a significant decrease was observed 
with 400 mg/kg of HEECP, i.e. 2.6 ± 0.67 (P < 0.05), when com‑
pared with the control group. HEECP (100, 200, and 400 mg/kg) 
showed insignificant difference compared to DZ. Potency of the 
extract (400 mg/kg) was found to be lesser than DZ [Figure 2].
Effect of DZ and HEECP on fecal bolus, rearing count, and 
head dip count in animals of the EPM model
The standard group (DZ, 2 mg/kg) showed significant 
decrease in fecal bolus count (0.4 ± 0.20; ***P < 0.001) as 
compared to the control group (6 ± 0.20), which indicates reduc‑
tion in anxiety. Equal significant decrease in fecal bolus count 
was observed with two different doses of HEECP (100 and 
200 mg/kg, i.e. 1 ± 0.10 (***P < 0.001), while no fecal bolus count 
was observed with HEECP dose 400 mg/kg. Test groups (100, 200, 
and 400 mg/kg) showed insignificant difference compared to the 
standard group. Potency of the extract (400 mg/kg) was found to be 
greater than the standard group [Figure 3]. DZ showed significant 
increase in rearing count (4 ± 1.32; ***P < 0.001) as compared 
to the control group (1 ± 0.45). Insignificant increase in rearing 
count was observed with HEECP 100 mg/kg (2 ± 0.32), while 
significant increase was observed for HEECP 200 and 400 mg/kg, 
i.e., 3 ± 0.40 (*P < 0.05) and 4 ± 1.0 (***P < 0.001), respectively, 
in comparison with the control group. Test group dose of 100 mg/
kg showed significant difference (*P < 0.05), while the test groups 
of doses 200 and 400 mg/kg showed insignificant difference in 
comparison to the standard group. Extract (400 mg/kg) was found 
to be equipotent to the standard group [Figure 3]. DZ and HEECP 
at 100, 200, and 400 mg/kg showed significant increase in head 
dip count (25 ± 1.1; ***P < 0.001) as compared to the control 
group (5 ± 1.0). Test group of 100 mg/kg showed significant 
difference (*P < 0.05), while the test groups of doses 200 and 
400 mg/kg showed insignificant difference in comparison with 
the standard group. Extract (400 mg/kg) was found to be a little 
bit lesser potent than the standard group [Figure 3].
Effect of DZ and HEECP on the time spent in light/dark 
compartment and duration of immobility in animals of the 
LandD model
Standard group (DZ, 2 mg/kg) showed significant increase in 
the time spent in light compartment (450 ± 18.99 sec; ***P < 0.001) 
as compared to the control group (131.8 ± 10.03 sec), which 
indicates reduction in anxiety. Significant increase in the 
time spent in light compartment was observed with HEECP 
at 100, 200, and 400 mg/kg, i.e. 291 ± 14.3 sec (P < 0.001), 
299 ± 21.5 sec (***P < 0.001), and 309 ± 24.3 sec (***P < 0.001), 
respectively, in comparison with the control group. Test groups 
of HEECP at 100 and 200 mg/kg showed significant differ‑
ence (***P < 0.001), while the test group at 400 mg/kg showed 
insignificant difference in comparison with the standard group. 
Test group with 400 mg/kg showed lesser potency than the standard 
group [Figure 4]. Standard group and test doses showed significant 
decrease in the time spent in dark compartment (***P < 0.001) 
as compared to the control group. Test groups with 100 and 
200 mg/kg showed significant difference (P < 0.001), while 
the test group dose of 400 mg/kg showed insignificant differ‑
ence in comparison with the standard group. Potency of the 
test group (400 mg/kg) was found to be lesser than the standard 
group [Figure 4]. DZ and HEECP at 200 and 400 mg/kg showed 
significant decrease in the duration of immobility as compared 
to the control group, while HEECP at 100 mg/kg showed insig‑
Figure 1. Effect of Diazepam & HEECP on time spent in open/ closed arm 
and latency (time spent in the centre of maze) on animals in EPM model
Figure 2. Effect of Diazepam & HEECP (100,200 & 400 mg/kg) on no. 
of entries in Open/closed arm on animals in EPM model
Figure 3. Effect of Diazepam & HEECP (100, 200 & 400 mg/kg) on faecal 
bolus, rearing count, head dip count on animals in EPM model
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nificant activity. HEECP at 100, 200, and 400 mg/kg showed 
insignificant difference in comparison with DZ. Potency of the 
test group of 400 mg/kg was found to be lesser than the standard 
group [Figure 4].
Effect of DZ and HEECP on the number of crossings in 
animals of the LandD model
Standard drug (DZ, 2 mg/kg) showed significant increase in the 
number of crossings (***P < 0.001), while HEECP at 100, 200, 
and 400 mg/kg showed insignificant difference when compared 
with the control group. HEECP at 100, 200, and 400 mg/kg showed 
significant difference (**P < 0.01, ***P < 0.001) when compared 
to the standard. HEECP at 400 mg/kg showed lesser potency than 
the standard group [Figure 5].
Effect of IM (2.5 mg/kg, p.o.) and HEECP on immobility/
swimming period in animals of FST model
Standard group (IM, 2.5 mg/kg) and HEECP at 200 and 
400 mg/kg showed significant decrease in the immobility pe‑
riod (***P < 0.001), while HEECP at 100 mg/kg was found to be 
insignificant when compared to the control group. HEECP (100, 
200, and 400 mg/kg) showed significant (***P < 0.001, 
**P < 0.01) difference compared to the standard group. Potency 
of HEECP 400 mg/kg was found to be lesser than the standard 
group [Figure 6]. DZ and HEECP 200 and 400 mg/kg also showed 
significant increase in the swimming period (***P < 0.001) as 
compared to the control group, while HEECP 100 mg/kg showed 
insignificant difference. HEECP at 100, 200, and 400 mg/kg 
showed significant difference (*P < 0.05, ***P < 0.001) when 
compared with the standard group (DZ; 2 mg/kg). Potency of 
HEECP (400 mg/kg) was found to be lesser than the standard 
group [Figure 6].
DISCUSSION
Natural molecules like linalool, hypericin, cardiospermin, 
chrysin, p‑coumaric acid, ferulic acid, sanjoinine A, obovatol, 
kaempferol, apigenin, imperatorin, isoimperatorin, etc., isolated 
from plants have shown promising anxiolytic activity.[2,12] The eti‑
ology of anxiety is not well known, but several studies revealed that 
dopaminergic and adrenergic systems and GABAergic and seroto‑
nergic neurotransmission are involved in the etiology, expression, 
and treatment of anxiety.[17‑19] Despite its widespread traditional 
use, there are no reports that scientifically provide the proof for 
the anxiolytic potential of C. pareira. The solvent has the capacity 
to extract the maximum number of constituents. Hydroethanolic 
extract of leaves of C. pareira is found to have anxiolytic‑like 
potential in behavioral models of murines, i.e. EPM, LandD, and 
FS models. EPM is highly sensitive to the influence of both anxio‑
lytic and anxiogenic drugs acting at the GABAA–BZD complex.
[20] 
EPM is considered one of the most validated models for assaying 
sedative and anxiolytic activity of drugs such as BZDs.[21] In EPM, 
the rats normally prefer to spend much of their allotted time in 
the closed arms. This preference appears to reflect an aversion 
toward open arms, which is generated by the fears of the open 
spaces. Drugs that increase open arm exploration are considered 
as anxiolytics and the reverse holds true for anxiogenics.[22] In this 
study, we observed that HEECP (200 and 400 mg//kg) induced 
significant activity in the EPM model.
The LandD test is widely used in rodent anxiety models to as‑
sess anxiolytic or anxiogenic‑like behavior of a drug. In the present 
study, rats spent more time in the light box and exhibited significant 
change in the number of transitions between the two boxes, which 
indicated an anxiolytic activity.[15] Anxiety related to stress is a 
component of severe depression in human beings. The incidence 
of anxiety and depression in the community is very high, and 
Figure 4. Effect of Diazepam & HEECP (100, 200 & 400 mg/kg) on time 
spent in light/dark compartment & duration of immobility on animals in 
light/dark model
Figure 5. Effect of Diazepam & HEECP (100, 200 & 400 mg/kg) on no. 
of crossings on animals in light/dark model
Figure 6. Effect of Imipramine (2.5 mg/kg) & HEECP (100, 200 & 
400 mg/kg) on immobility/swimming period on animals in FST model 
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associated with considerable morbidity. Hence, addressing these 
problems and finding effective remedies is extremely important. 
Several drugs are available, but all are associated with limitations, 
and there is an urgent need for alternative medications for these 
disorders. The FS test has been validated as a suitable tool for pre‑
dicting the antidepressant properties of drugs. It is a behavioral test 
in rodents that gives an indication of the clinical effectiveness of 
various types of antidepressant drugs. This model helps to assess the 
antidepressant action and identify the anxiolytics for those anxiety 
which is in combination with depression from nature.[14,15] The ac‑
tive constituents of HEECP have to pass the blood–brain barrier in 
order to produce any pharmacological effects. Previous reports on 
the phytochemicals and pharmacology suggest that plants contain‑
ing alkaloids, flavanoids, and terpenoids possess activity against 
many CNS disorders.[23] Phytochemical tests of HEECP revealed 
the presence of alkaloids and flavanoids, terpenoids, phenolics, 
etc., It may be possible that the mechanism of anxiolytic action of 
HEECP could be due to the binding of any of these phytochemi‑
cals to the GABAA–BZD complex. In support of this, it has been 
found that berberine alkaloids bind with high‑affinity BZD site 
of the GABAA receptor
[24] and C. pareira also contains berberine 
and flavones which may be responsible for its anxiolytic activity. 
So, the anxiolytic activity of HEECP might involve an action on 
GABAergic transmission or effects on serotonergic transmission 
or may be due to its combinatorial effect. The detailed mechanism 
of action is needed to be screened and established. Hence, this 
research paves a way for further evaluation and isolation of active 
molecules from the plant for anxiolytic potential.
ACKNOWLEDGMENTS
The authors would like to thank Rayat Institute of Pharmacy, 
Ropar, Nawanshahr, Punjab, India for lab facilities. They would 
also like to thank Professor Zulfiqar Ali Bhat (Department of 
Pharmaceutical Sciences, University of Kashmir, Srinagar, India) 
for authentication of plant material and Dr. Dinesh Kumar (De‑
partment of Pharmaceutical Sciences, Tashwane University of 
Technology, Pretoria, South Africa) for helping in collection of 
plant material and research work.
REFERENCES
1. Kulkarni SK, Reddy DS. Animal behavioural models for testing 
anti‑anxiety agents. Methods Find Exp Clin Pharmacol 1996;18: 219‑3.
2. Kumar D, Bhat ZA, Kumar V, Shah MY. Coumarins from Angelica 
archangelica Linn and their effects on anxiety‑like behavior. Prog 
Neuropsychopharmacol Biol Psychiatry 2013;40:180‑6.
3. Kumar D, Bhat ZA, Shah MY. Effect of successive extracts of Stachys 
tibeticaVatke (Lamiaceae) in anxiety. Orient Pharm Exp Med 2012a; 
12: 247‑53.
4. Kulkarni SK, Singh K, Bishnoi M. Comparative behavioral profile 
of newer antianxiety drugs on different mazes. Indian J Exp Biol 
2008;46:633‑8.
5. Kumar D, Bhat ZA, Shah MY. Anti‑anxiety activity of successive 
extracts of Angelica archangelica linn on the elevated T‑maze and forced 
swimming tests in rats. J Tradit Chin Med 2012;32:423‑9.
6. Rabbani M, Sajjadi SE, Mohammad A. Evaluation of the anxiolytic effect 
of Nepetapersica Boiss. in mice. Evid Based Complement Alternat Med 
2008;5:181‑6.
7. Amresh G, Reddy GD, Rao ChV, Singh PN. Evaluation of 
anti‑inflammatory activity of Cissampelos pareira root in rats. J 
Ethnopharmacol 2007;110:526‑31.
8. Amresh G, Singh PN, Rao CV. Toxicological screening of traditional 
medicine Laghupatha (Cissampelos pareira) in experimental animals. 
J Ethnopharmacol 2008;116:454‑60.
9. Akah PA, Nwafor SV. Studies on anti‑ulcer properties of 
Cissampelosmucronata leaf extract. Indian J Exp Biol 1999;37:936‑8.
10. Bafna AR, Mishra SH. Immunomodulatory activity of methanol extract 
of roots of Cissampelos pareira Linn. Ars Pharm 2005;46:253‑62.
11. Wagner H, Bladt S. Plant drug analysis, 2nd ed. Singapore: Springer Verlag 
Publication; 1996. p. 349‑64.
12. Kumar D, Bhat ZA, Kumar V, Shah MY. Nature: Anxiolytics in the lap of 
nature. Webmed Central Pharmaceutical Sciences 2011;2:WMC002140.
13. Rodgers RJ, Johnson NJ. Factor analysis of spatiotemporal and 
ethological measures in the murine elevated plus‑maze. Pharmacol 
Biochem Behav 1995;52:297‑303.
14. Kumar D, Bhat ZA, Kumar V, Khan NA, Chashoo IA, Zargar MI, et al. 
Effects of Stachys tibetica essential oil in anxiety. Eur J Integr Med 
2012;4:e169‑76.
15. Kumar D, Bhat ZA. Anxiolytic activity of aqueous extract of Angelica 
archangelica Linn, Inventi Rapid: Ethnopharmacology 2012;2: 
Inventi: pep/596/12.
16. Petit‑Demouliere B, Chenu F, Bourin M. Forced swimming test in 
mice: A review of antidepressant activity. Psychopharmacology (Berl) 
2005;177:245‑55.
17. Graeff FG, Guimares FS, de‑Andrade TG, Deakin JF. Role of 
5‑HT in stress, anxiety and depression. Pharmacol Biochem Behav 
1996;54:129‑41.
18. Griebel G. 5‑hydroxytryptamine pathways in anxiety and its treatment. 
Pharmacol Ther 1995;66:103‑48.
19. Clement Y, Chapouthier G. Biological bases of anxiety. Neurosci 
Biobehav Rev 1998;22:623‑33.
20. Dhonnchadha BA, Bourin M, Hascoet M. Anxiolytic‑like effects of 
5‑HT2 ligands on three mouse models of Anxiety. Behav Brain Res 
2003;140:203‑14.
21. Maribel HR, Yolanda GB, Sergio M, Gabriela DV, Glauce SB, Jaime T, 
et al. Antidepressant and anxiolytic effects of hydroalcoholic extract from 
Salvia elegans. J Ethnopharmacol 2006;107:53‑8.
22. Hellion‑Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, 
Heinichen O, Campuzanoa M, et al. The anxiolytic‑like effects of 
Aloysiapolystachya (Griseb.) Moldenke (Verbenaceae) in mice. 
J Ethnopharmacol 2006;105:400‑8.
23. Bhattacharya SK, Satyan KS. Experimental methods for evaluation of 
psychotropic agents in rodents: I‑Anti‑anxiety agents. Indian J Exp Biol 
1997;35:565‑75.
24. Adeyemi OO, Yemitan OK, Taiwo AE. Neurosedative and 
muscle‑relaxant activities of ethyl acetate extract of Baphianitida AFZEL. 
J Ethnopharmacol 2006;106:312‑6.
